000963 华东医药
已收盘 11-12 15:00:00
资讯
新帖
简况
华东医药（000963）11月11日主力资金净卖出5379.97万元
证券之星 · 09:23
华东医药（000963）11月11日主力资金净卖出5379.97万元
华东医药（000963）11月9日主力资金净卖出5102.12万元
证券之星 · 11-10 10:31
华东医药（000963）11月9日主力资金净卖出5102.12万元
11月5日华东医药现210.76万元大宗交易
证券之星 · 11-05
11月5日华东医药现210.76万元大宗交易
华东医药：集采是医药行业共性挑战
证券之星 · 11-04
华东医药：集采是医药行业共性挑战
股市必读：华东医药新发布《关于全资子公司收到药品注册受理通知书的公告》
证券之星 · 11-04
股市必读：华东医药新发布《关于全资子公司收到药品注册受理通知书的公告》
华东医药(000963.SZ)子公司卡维列隆氨丁三醇片上市许可申请获受理
智通财经 · 11-03
华东医药(000963.SZ)子公司卡维列隆氨丁三醇片上市许可申请获受理
华东医药：1类新药卡维列隆氨丁三醇片用于成人长期体重控制的上市申请获受理
格隆汇 · 11-03
华东医药：1类新药卡维列隆氨丁三醇片用于成人长期体重控制的上市申请获受理
国产口服GLP-1第一梯队再添猛将！华东医药(000963.SZ)自研1类新药卡维列隆氨丁三醇片中国上市申请获受理
智通财经 · 11-03
国产口服GLP-1第一梯队再添猛将！华东医药(000963.SZ)自研1类新药卡维列隆氨丁三醇片中国上市申请获受理
华东医药：公司长期愿景是成为以科研创新驱动的国际化品牌医药强企
证券之星 · 11-03
华东医药：公司长期愿景是成为以科研创新驱动的国际化品牌医药强企
华东医药（000963）11月2日主力资金净买入2143.45万元
证券之星 · 11-03
华东医药（000963）11月2日主力资金净买入2143.45万元
华东医药（000963）10月30日主力资金净卖出7780.11万元
证券之星 · 11-02
华东医药（000963）10月30日主力资金净卖出7780.11万元
股市必读：华东医药三季报 - 第三季度单季净利润同比下降2.35%
证券之星 · 10-30
股市必读：华东医药三季报 - 第三季度单季净利润同比下降2.35%
华东医药(000963)9月30日股东户数12.7万户，较上期增加26.75%
证券之星 · 10-29
华东医药(000963)9月30日股东户数12.7万户，较上期增加26.75%
华东医药：第十一届董事会第八次会议决议公告
证券日报网 · 10-28
华东医药：第十一届董事会第八次会议决议公告
华东医药最新公告：前三季度净利润同比增长0.87%
证券之星 · 10-28
华东医药最新公告：前三季度净利润同比增长0.87%
瑞银将华东医药评级下调至中性，目标价28元。
格隆汇 · 10-22
瑞银将华东医药评级下调至中性，目标价28元。
佐力药业：公司及子公司与华东医药的购销属于商业化业务往来
证券之星 · 10-22
佐力药业：公司及子公司与华东医药的购销属于商业化业务往来
瑞银：降联邦制药评级至“中性” 重申先声药业为首选
同花顺 · 10-22
瑞银：降联邦制药评级至“中性” 重申先声药业为首选
华东医药（000963）披露控股子公司获得药物临床试验批准通知书，10月19日股价上涨0.91%
证券之星 · 10-19
华东医药（000963）披露控股子公司获得药物临床试验批准通知书，10月19日股价上涨0.91%
全球首创三靶点激动剂DR10624入选AASLD最新突破摘要 华东医药代谢领域布局再获国际认可
同花顺 · 10-19
全球首创三靶点激动剂DR10624入选AASLD最新突破摘要 华东医药代谢领域布局再获国际认可
暂无数据
公司概况
公司名称：
华东医药股份有限公司
所属行业：
零售业
上市日期：
2000-01-27
主营业务：
华东医药股份有限公司的主营业务是专科、慢病及特殊用药领域的研发、生产和销售。公司的主要产品是慢性肾病用药、免疫用药、肿瘤用药、内分泌用药、消化系统用药、心血管用药。
发行价格：
5.76
{"stockData":{"symbol":"000963","market":"SZ","secType":"STK","nameCN":"华东医药","latestPrice":26.22,"timestamp":1794467019000,"preClose":26.56,"halted":0,"volume":15885970,"delay":0,"changeRate":-0.0128,"floatShares":1753000000,"shares":1754000000,"eps":1.9606,"marketStatus":"已收盘","change":-0.34,"latestTime":"11-12 15:00:00","open":26.45,"high":26.65,"low":26.18,"amount":419000000,"amplitude":0.0177,"askPrice":26.23,"askSize":328,"bidPrice":26.22,"bidSize":151,"shortable":0,"etf":0,"ttmEps":1.9606,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794533400000},"marketStatusCode":5,"adr":0,"adjPreClose":26.56,"symbolType":"stock","openAndCloseTimeList":[[1794447000000,1794454200000],[1794459600000,1794466800000]],"highLimit":29.22,"lowLimit":23.9,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1753736848,"isCdr":false,"pbRate":1.81,"roa":"--","peRate":13.373457,"roe":"10.84%","epsLYR":1.9484,"committee":0.822081,"marketValue":45983000000,"turnoverRate":0.0091,"status":1,"floatMarketCap":45964000000},"requestUrl":"/m/hq/s/000963/tweets","defaultTab":"tweets","newsList":[{"id":"2682539771","title":"华东医药（000963）11月11日主力资金净卖出5379.97万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682539771","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682539771?lang=zh_cn&edition=full","pubTime":"2026-11-12 09:23","pubTimestamp":1794446594,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年11月11日收盘，华东医药报收于26.56元，下跌1.15%，换手率0.8%，成交量14.11万手，成交额3.76亿元。近5日资金流向一览见下表：华东医药融资融券信息显示，融资方面，当日融资买入4609.13万元，融资偿还3521.13万元，融资净买入1088.0万元，连续3日净买入累计4329.12万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111200007630.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","LU1969619763.USD","BK0175","BK0188","BK0132","LU2328871848.SGD","BK0196","000963","BK0209","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682135134","title":"华东医药（000963）11月9日主力资金净卖出5102.12万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682135134","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682135134?lang=zh_cn&edition=full","pubTime":"2026-11-10 10:31","pubTimestamp":1794277900,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年11月9日收盘，华东医药报收于27.05元，下跌2.42%，换手率0.91%，成交量16.02万手，成交额4.37亿元。近5日资金流向一览见下表：华东医药融资融券信息显示，融资方面，当日融资买入5198.72万元，融资偿还3295.45万元，融资净买入1903.26万元。华东医药主营业务：业务覆盖医药全产业链,拥有医药工业、医药商业、医美、工业微生物四大业务板块,已发展成为集医药研发、生产、经销为一体的大型综合性医药上市公司。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111000011688.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","000963","BK0175","BK0187","LU2328871848.SGD","BK0132","BK0196","BK0183","LU1969619763.USD","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681040129","title":"11月5日华东医药现210.76万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2681040129","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681040129?lang=zh_cn&edition=full","pubTime":"2026-11-05 17:57","pubTimestamp":1793872646,"startTime":"0","endTime":"0","summary":"证券之星消息，11月5日华东医药发生大宗交易，交易数据如下：大宗交易成交价格27.99元，成交7.53万股，成交金额210.76万元，买方营业部为机构专用，卖方营业部为机构专用。近三个月该股共发生1笔大宗交易，合计成交753.0手。该股近期无解禁股上市。截至2026年11月5日收盘，华东医药(000963)报收于27.99元，上涨1.41%，换手率1.26%，成交量22.12万手，成交额6.15亿元。该股最近90天内共有9家机构给出评级，买入评级8家，增持评级1家；过去90天内机构目标均价为39.59。本文数据来源于深圳证券交易所大宗交易信息披露，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110500031686.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0175","BK0132","LU1969619763.USD","BK0187","BK0196","BK0209","000963","LU2328871848.SGD","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680088200","title":"华东医药：集采是医药行业共性挑战","url":"https://stock-news.laohu8.com/highlight/detail?id=2680088200","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680088200?lang=zh_cn&edition=full","pubTime":"2026-11-04 11:37","pubTimestamp":1793763434,"startTime":"0","endTime":"0","summary":"集采是医药行业共性挑战，公司已较早主动推动业务结构和战略转型，持续布局创新药、医美、工业微生物等高附加值赛道，转型成效仍在释放。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400017085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0187","LU1969619763.USD","BK0188","BK0209","BK0183","000963","LU2328871848.SGD","BK0196","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680776100","title":"股市必读：华东医药新发布《关于全资子公司收到药品注册受理通知书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2680776100","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680776100?lang=zh_cn&edition=full","pubTime":"2026-11-04 01:54","pubTimestamp":1793728480,"startTime":"0","endTime":"0","summary":"截至2026年11月3日收盘，华东医药报收于27.19元，上涨2.53%，换手率1.23%，成交量21.59万手，成交额5.83亿元。公司公告汇总关于全资子公司收到药品注册受理通知书的公告2026年11月2日，华东医药全资子公司杭州中美华东制药有限公司收到国家药品监督管理局签发的《受理通知书》，其自主研发的口服小分子GLP-1受体激动剂卡维列隆氨丁三醇片用于成人长期体重控制的上市许可申请已获受理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400003432.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0175","LU1969619763.USD","LU2328871848.SGD","BK0188","BK0132","BK0183","BK0187","000963","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680725026","title":"华东医药(000963.SZ)子公司卡维列隆氨丁三醇片上市许可申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2680725026","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680725026?lang=zh_cn&edition=full","pubTime":"2026-11-03 20:15","pubTimestamp":1793708143,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华东医药 发布公告，2026年11月2日，公司全资子公司杭州中美华东制药有限公司收到国家药品监督管理局签发的《受理通知书》，口服小分子胰高血糖素样肽-1受体激动剂卡维列隆氨丁三醇片用于成人长期体重控制的上市许可申请获得受理。截至2026年9月30日，公司在卡维列隆氨丁三醇片项目的研发直接投入总金额约为5.07亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1517983.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0175","000963","BK0209","BK0183","BK0188","IPOS","LU2328871848.SGD","BK0196","LU1969619763.USD","BK0187","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680725533","title":"华东医药：1类新药卡维列隆氨丁三醇片用于成人长期体重控制的上市申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2680725533","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680725533?lang=zh_cn&edition=full","pubTime":"2026-11-03 20:05","pubTimestamp":1793707551,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0196","BK0187","000963","BK0209","BK0175","BK0183","BK0188","LU2328871848.SGD","BK0132","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680723229","title":"国产口服GLP-1第一梯队再添猛将！华东医药(000963.SZ)自研1类新药卡维列隆氨丁三醇片中国上市申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2680723229","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680723229?lang=zh_cn&edition=full","pubTime":"2026-11-03 19:58","pubTimestamp":1793707085,"startTime":"0","endTime":"0","summary":"华东医药自主研发的卡维列隆氨丁三醇片，正是精准锚定这一市场空白的核心品种。本次卡维列隆氨丁三醇片上市申请获国家药监局受理，是华东医药代谢创新管线推进过程中的重要里程碑，也有望助力公司抢占国内口服小分子GLP-1赛道的先发卡位优势，为国内 GLP-1市场填补口服剂型的关键空白。自主研发的卡维列隆氨丁三醇片此次获NMPA受理，进入审评阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1517963.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0183","BK0187","LU1969619763.USD","BK0175","BK0188","IPOS","LU2328871848.SGD","BK0132","BK0209","000963","JDOC","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680771591","title":"华东医药：公司长期愿景是成为以科研创新驱动的国际化品牌医药强企","url":"https://stock-news.laohu8.com/highlight/detail?id=2680771591","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680771591?lang=zh_cn&edition=full","pubTime":"2026-11-03 11:36","pubTimestamp":1793676986,"startTime":"0","endTime":"0","summary":"证券之星消息，华东医药11月02日在投资者关系平台上答复投资者关心的问题。公司长期愿景是成为以科研创新驱动的国际化品牌医药强企，建设跨国医药企业是公司既定长期战略，契合浙江企业外向发展的特质。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300018532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK1161","BK0187","000963","BK0209","BK1515","BK0175","BK0183","BK0188","LU2328871848.SGD","159938","BK1574","09939","BK0132","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680420790","title":"华东医药（000963）11月2日主力资金净买入2143.45万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680420790","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680420790?lang=zh_cn&edition=full","pubTime":"2026-11-03 09:48","pubTimestamp":1793670511,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年11月2日收盘，华东医药报收于26.52元，下跌0.38%，换手率0.99%，成交量17.3万手，成交额4.59亿元。近5日资金流向一览见下表：华东医药融资融券信息显示，融资方面，当日融资买入5030.37万元，融资偿还4396.36万元，融资净买入634.01万元。华东医药主营业务：业务覆盖医药全产业链,拥有医药工业、医药商业、医美、工业微生物四大业务板块,已发展成为集医药研发、生产、经销为一体的大型综合性医药上市公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300014917.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0187","000963","BK0209","BK0175","BK0183","BK0188","LU2328871848.SGD","BK0132","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680786991","title":"华东医药（000963）10月30日主力资金净卖出7780.11万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680786991","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680786991?lang=zh_cn&edition=full","pubTime":"2026-11-02 09:06","pubTimestamp":1793581570,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月30日收盘，华东医药报收于26.62元，上涨2.86%，换手率1.52%，成交量26.69万手，成交额7.07亿元。近5日资金流向一览见下表：华东医药融资融券信息显示，融资方面，当日融资买入3318.76万元，融资偿还6798.13万元，融资净偿还3479.37万元。华东医药主营业务：业务覆盖医药全产业链,拥有医药工业、医药商业、医美、工业微生物四大业务板块,已发展成为集医药研发、生产、经销为一体的大型综合性医药上市公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200003267.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0175","BK0132","LU1969619763.USD","BK0187","BK0196","BK0209","000963","LU2328871848.SGD","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679232145","title":"股市必读：华东医药三季报 - 第三季度单季净利润同比下降2.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679232145","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679232145?lang=zh_cn&edition=full","pubTime":"2026-10-30 05:28","pubTimestamp":1793309306,"startTime":"0","endTime":"0","summary":"截至2026年10月29日收盘，华东医药报收于25.88元，下跌0.96%，换手率0.82%，成交量14.33万手，成交额3.71亿元。股本股东变化：截至2026年9月30日股东户数达12.7万户，较6月30日增长26.75%。业绩披露要点：2026年前三季度归母净利润27.72亿元，同比上升0.87%；第三季度单季度归母净利润9.11亿元，同比下降2.35%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000006819.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000963"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679033004","title":"华东医药(000963)9月30日股东户数12.7万户，较上期增加26.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679033004","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679033004?lang=zh_cn&edition=full","pubTime":"2026-10-29 19:02","pubTimestamp":1793271724,"startTime":"0","endTime":"0","summary":"证券之星消息，近日华东医药披露，截至2026年9月30日公司股东户数为12.7万户，较6月30日增加2.68万户，增幅为26.75%。在化学制药行业个股中，华东医药股东户数高于行业平均水平，截至9月30日，化学制药行业平均股东户数为3.95万户。从股价来看，2026年6月30日至2026年9月30日，华东医药区间跌幅为0.19%，在此期间股东户数增加2.68万户，增幅为26.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900045440.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0209","BK0132","BK0188","BK0183","BK0187","000963","LU1969619763.USD","LU2328871848.SGD","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678997384","title":"华东医药：第十一届董事会第八次会议决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2678997384","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678997384?lang=zh_cn&edition=full","pubTime":"2026-10-28 21:32","pubTimestamp":1793194320,"startTime":"0","endTime":"0","summary":"证券日报网讯 10月28日，华东医药发布公告称，公司于2026年10月28日召开第十一届董事会第八次会议，审议通过《关于公司〈2026年第三季度报告〉的议案》。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-10-28/doc-iniwuzmt5785109.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-10-28/doc-iniwuzmt5785109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0132","BK0183","BK0196","BK0209","LU1969619763.USD","000963","BK0187","LU2328871848.SGD","BK0175","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678678604","title":"华东医药最新公告：前三季度净利润同比增长0.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678678604","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678678604?lang=zh_cn&edition=full","pubTime":"2026-10-28 20:00","pubTimestamp":1793188820,"startTime":"0","endTime":"0","summary":"华东医药(000963.SZ)公告称，第三季度营业收入为109.52亿元，同比下降0.33%；归属于上市公司股东的净利润为9.11亿元，同比下降2.35%。前三季度实现营业收入330.19亿元，同比增长1.09%；归属于上市公司股东的净利润27.72亿元，同比增长0.87%。注：公司Q3净利润9.11亿，Q2净利润8.59亿，据此计算，Q3净利润环比增长6%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800045866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000963"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677195216","title":"瑞银将华东医药评级下调至中性，目标价28元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2677195216","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677195216?lang=zh_cn&edition=full","pubTime":"2026-10-22 19:06","pubTimestamp":1792667193,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0132","BK0188","BK0175","LU2328871848.SGD","BK0209","BK0183","LU1969619763.USD","BK0196","BK0187","000963"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677995340","title":"佐力药业：公司及子公司与华东医药的购销属于商业化业务往来","url":"https://stock-news.laohu8.com/highlight/detail?id=2677995340","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677995340?lang=zh_cn&edition=full","pubTime":"2026-10-22 17:12","pubTimestamp":1792660329,"startTime":"0","endTime":"0","summary":"公司及子公司与华东医药的购销属于商业化业务往来，基于市场化条件协商定价，不存在利益交换或利益输送。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200029340.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","300181","BK0209","BK0187","BK0183","LU1969619763.USD","BK0077","BK0188","LU2328871848.SGD","000963","BK0196","BK0175","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677953822","title":"瑞银：降联邦制药评级至“中性” 重申先声药业为首选","url":"https://stock-news.laohu8.com/highlight/detail?id=2677953822","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677953822?lang=zh_cn&edition=full","pubTime":"2026-10-22 16:47","pubTimestamp":1792658820,"startTime":"0","endTime":"0","summary":"瑞银发布研报称，重新审视中国制药覆盖范围的增长前景，评估现有重磅产品是否已见顶，以及下一批50亿元人民币级产品可能来自何处;该行重申先声药业(02096)为首选，同时将联邦制药(03933)及 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20261022/c680982128.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20261022/c680982128.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["BK0196","BK0183","LU2328871848.SGD","BK0209","LU1969619763.USD","BK0187","BK0188","BK0175","BK0132","000963"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676845504","title":"华东医药（000963）披露控股子公司获得药物临床试验批准通知书，10月19日股价上涨0.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676845504","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676845504?lang=zh_cn&edition=full","pubTime":"2026-10-19 17:22","pubTimestamp":1792401776,"startTime":"0","endTime":"0","summary":"截至2026年10月19日收盘，华东医药报收于26.49元，较前一交易日上涨0.91%，最新总市值为464.56亿元。近日，华东医药披露关于控股子公司获得药物临床试验批准通知书的公告。目前已在中国获批多项临床试验，本次获批进一步推进其在肿瘤治疗领域的发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900022058.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0132","BK0187","000963","BK0175","LU1969619763.USD","LU2328871848.SGD","BK0209","BK0188","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676509376","title":"全球首创三靶点激动剂DR10624入选AASLD最新突破摘要 华东医药代谢领域布局再获国际认可","url":"https://stock-news.laohu8.com/highlight/detail?id=2676509376","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676509376?lang=zh_cn&edition=full","pubTime":"2026-10-19 16:25","pubTimestamp":1792398300,"startTime":"0","endTime":"0","summary":"2026年10月19日，华东医药股份有限公司(以下简称“华东医药”)对外宣布，其控股子公司浙江道尔生物科技有限公司(以下简称“道尔生物”)自主研发的同类首创(First-in-class)长效三特异性激动 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261019/c680836661.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261019/c680836661.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK0188","BK0175","BK0132","LU1969619763.USD","BK0187","BK0196","BK0209","000963","LU2328871848.SGD","BK0183"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794472155148,"stockEarnings":[{"period":"1week","weight":-0.0377},{"period":"1month","weight":-0.0119},{"period":"3month","weight":-0.0893},{"period":"6month","weight":-0.1217},{"period":"1year","weight":-0.3547},{"period":"ytd","weight":-0.3031}],"compareEarnings":[{"period":"1week","weight":-0.0015},{"period":"1month","weight":-0.0307},{"period":"3month","weight":-0.0627},{"period":"6month","weight":-0.11},{"period":"1year","weight":-0.0805},{"period":"ytd","weight":-0.0726}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华东医药股份有限公司","boardCode":"AI0052","boardName":"零售业","stockholders":"126994人(较上一季度增加26.75%)","perCapita":"13803股","listingDate":"2000-01-27","address":"浙江省杭州市拱墅区中山北路439号4、7楼","registeredCapital":"175373万元","survey":" 华东医药股份有限公司的主营业务是专科、慢病及特殊用药领域的研发、生产和销售。公司的主要产品是慢性肾病用药、免疫用药、肿瘤用药、内分泌用药、消化系统用药、心血管用药。","listedPrice":5.76},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华东医药(000963)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华东医药(000963)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华东医药,000963,华东医药股票,华东医药股票老虎,华东医药股票老虎国际,华东医药行情,华东医药股票行情,华东医药股价,华东医药股市,华东医药股票价格,华东医药股票交易,华东医药股票购买,华东医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华东医药(000963)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华东医药(000963)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}